Crossmark

Systematic review and meta analysis of efficacy and safety of immunotherapy plus chemotherapy versus chemotherapy in non small cell lung cancer without EGFR or ALK alterations

Crossref DOI link: https://doi.org/10.1007/s44337-025-00514-3

Published Online: 2025-12-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abdelazim, Karim https://orcid.org/0000-0001-6598-9188
Amralla, Mohamed T. https://orcid.org/0000-0001-8027-8173
Aboismael, Ali A. https://orcid.org/0009-0005-6664-4540
Ghaffar, Shrouk A. https://orcid.org/0009-0006-3308-9461
Elbehiry, Ahmed I.

Badr, Nahla H. https://orcid.org/0000-0001-6262-6509
License Information

Text and Data Mining valid from 2025-12-10

Version of Record valid from 2025-12-10
More Information

Article History

Received: 18 April 2025

Accepted: 1 October 2025

First Online: 10 December 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below